The North America Corneal Implants Market would witness market growth of 5.7% CAGR during the forecast period (2023-2029).
Bioengineered corneal implants are made using tissue engineering techniques to produce corneal implants from living cells. These implants may provide greater biocompatibility, a lower risk of problems, and better visual outcomes when compared to conventional synthetic implants.
Thus, the development of cutting-edge technologies is anticipated to fuel the expansion of the corneal implants market throughout the anticipated period. The market for corneal implants is also expected to grow due to rising demand for corneal transplants, better healthcare infrastructure, and prospects in developing nations. Also, there has been a huge increase in public knowledge of corneal transplantation, which spurs the market's expansion.
In the US, 4% of adults over the age of 40 have the late-onset variant of Fuchs endothelial dystrophy, which is a frequent disorder. The exact prevalence of the early-onset Fuchs endothelial dystrophy variety is yet unknown. However, for unknown reasons, women are two to four times more likely than men to develop Fuchs endothelial dystrophy. In addition, Fuchs endothelial dystrophy is uncertain in its genetics. The development of Fuchs endothelial dystrophy is thought to be influenced by various genes and areas found within a few chromosomes. Thus, these factors are propelling the market growth in the North America region.
The US market dominated the North America Corneal Implants Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $173.2 million by 2029. The Canada market is poised to grow at a CAGR of 8.2% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 7.2% during (2023 - 2029).
Based on Disease Type, the market is segmented into Fuchs' Dystrophy, Keratoconus, Infectious Keratitis and Others. Based on Procedure Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, and Others. Based on End User, the market is segmented into Hospitals, Ophthalmic Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Corneal Implants Market is Projected to reach USD 595.1 Million by 2029, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Presbia PLC, CorNeat Vision Ltd., Alcon, Inc., AJL Opthalmic SA, LinkoCare Life Sciences AB, CorneaGen, DIOPTEX GmbH, Mediphacos Industrias Medicas S.A., EyeYon Medical Ltd., and KeraMed, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Fuchs' Dystrophy
- Keratoconus
- Infectious Keratitis
- Others
By Procedure Type
- Penetrating Keratoplasty
- Endothelial Keratoplasty
- Others
By End User
- Hospitals
- Ophthalmic Centers
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Presbia PLC
- CorNeat Vision Ltd.
- Alcon, Inc.
- AJL Opthalmic SA
- LinkoCare Life Sciences AB
- CorneaGen
- DIOPTEX GmbH
- Mediphacos Industrias Medicas S.A.
- EyeYon Medical Ltd.
- KeraMed, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Corneal Implants Market, by Disease Type
1.4.2 North America Corneal Implants Market, by Procedure Type
1.4.3 North America Corneal Implants Market, by End User
1.4.4 North America Corneal Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Corneal implants Market
Chapter 4. North America Corneal Implants Market by Disease Type
4.1 North America Fuchs' Dystrophy Market by Country
4.2 North America Keratoconus Market by Country
4.3 North America Infectious Keratitis Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Corneal Implants Market by Procedure Type
5.1 North America Penetrating Keratoplasty Market by Country
5.2 North America Endothelial Keratoplasty Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Corneal Implants Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Ophthalmic Centers Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Corneal Implants Market by Country
7.1 US Corneal Implants Market
7.1.1 US Corneal Implants Market by Disease Type
7.1.2 US Corneal Implants Market by Procedure Type
7.1.3 US Corneal Implants Market by End User
7.2 Canada Corneal Implants Market
7.2.1 Canada Corneal Implants Market by Disease Type
7.2.2 Canada Corneal Implants Market by Procedure Type
7.2.3 Canada Corneal Implants Market by End User
7.3 Mexico Corneal Implants Market
7.3.1 Mexico Corneal Implants Market by Disease Type
7.3.2 Mexico Corneal Implants Market by Procedure Type
7.3.3 Mexico Corneal Implants Market by End User
7.4 Rest of North America Corneal Implants Market
7.4.1 Rest of North America Corneal Implants Market by Disease Type
7.4.2 Rest of North America Corneal Implants Market by Procedure Type
7.4.3 Rest of North America Corneal Implants Market by End User
Chapter 8. Company Profiles
8.1 Alcon, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 CorneaGen
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.2.2.3 Acquisition and Mergers:
8.3 CorNeat Vision Ltd.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.4 EyeYon Medical Ltd.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Trials and Approvals:
8.5 Presbia PLC
8.5.1 Company Overview
8.6 AJL Ophthalmic S.A.
8.6.1 Company Overview
8.7 LinkoCare Life Sciences AB
8.7.1 Company Overview
8.8 KeraMed, Inc.
8.8.1 Company Overview
8.9 DIOPTEX GmbH
8.9.1 Company Overview
8.10. Mediphacos Indústrias Médicas S.A.
8.10.1 Company Overview
TABLE 1 North America Corneal Implants Market, 2019 - 2022, USD Million
TABLE 2 North America Corneal Implants Market, 2023 - 2029, USD Million
TABLE 3 North America Corneal Implants Market by Disease Type, 2019 - 2022, USD Million
TABLE 4 North America Corneal Implants Market by Disease Type, 2023 - 2029, USD Million
TABLE 5 North America Fuchs' Dystrophy Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Fuchs' Dystrophy Market by Country, 2023 - 2029, USD Million
TABLE 7 North America Keratoconus Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Keratoconus Market by Country, 2023 - 2029, USD Million
TABLE 9 North America Infectious Keratitis Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Infectious Keratitis Market by Country, 2023 - 2029, USD Million
TABLE 11 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 13 North America Corneal Implants Market by Procedure Type, 2019 - 2022, USD Million
TABLE 14 North America Corneal Implants Market by Procedure Type, 2023 - 2029, USD Million
TABLE 15 North America Penetrating Keratoplasty Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Penetrating Keratoplasty Market by Country, 2023 - 2029, USD Million
TABLE 17 North America Endothelial Keratoplasty Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Endothelial Keratoplasty Market by Country, 2023 - 2029, USD Million
TABLE 19 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 21 North America Corneal Implants Market by End User, 2019 - 2022, USD Million
TABLE 22 North America Corneal Implants Market by End User, 2023 - 2029, USD Million
TABLE 23 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 25 North America Ophthalmic Centers Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Ophthalmic Centers Market by Country, 2023 - 2029, USD Million
TABLE 27 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 29 North America Corneal Implants Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Corneal Implants Market by Country, 2023 - 2029, USD Million
TABLE 31 US Corneal Implants Market, 2019 - 2022, USD Million
TABLE 32 US Corneal Implants Market, 2023 - 2029, USD Million
TABLE 33 US Corneal Implants Market by Disease Type, 2019 - 2022, USD Million
TABLE 34 US Corneal Implants Market by Disease Type, 2023 - 2029, USD Million
TABLE 35 US Corneal Implants Market by Procedure Type, 2019 - 2022, USD Million
TABLE 36 US Corneal Implants Market by Procedure Type, 2023 - 2029, USD Million
TABLE 37 US Corneal Implants Market by End User, 2019 - 2022, USD Million
TABLE 38 US Corneal Implants Market by End User, 2023 - 2029, USD Million
TABLE 39 Canada Corneal Implants Market, 2019 - 2022, USD Million
TABLE 40 Canada Corneal Implants Market, 2023 - 2029, USD Million
TABLE 41 Canada Corneal Implants Market by Disease Type, 2019 - 2022, USD Million
TABLE 42 Canada Corneal Implants Market by Disease Type, 2023 - 2029, USD Million
TABLE 43 Canada Corneal Implants Market by Procedure Type, 2019 - 2022, USD Million
TABLE 44 Canada Corneal Implants Market by Procedure Type, 2023 - 2029, USD Million
TABLE 45 Canada Corneal Implants Market by End User, 2019 - 2022, USD Million
TABLE 46 Canada Corneal Implants Market by End User, 2023 - 2029, USD Million
TABLE 47 Mexico Corneal Implants Market, 2019 - 2022, USD Million
TABLE 48 Mexico Corneal Implants Market, 2023 - 2029, USD Million
TABLE 49 Mexico Corneal Implants Market by Disease Type, 2019 - 2022, USD Million
TABLE 50 Mexico Corneal Implants Market by Disease Type, 2023 - 2029, USD Million
TABLE 51 Mexico Corneal Implants Market by Procedure Type, 2019 - 2022, USD Million
TABLE 52 Mexico Corneal Implants Market by Procedure Type, 2023 - 2029, USD Million
TABLE 53 Mexico Corneal Implants Market by End User, 2019 - 2022, USD Million
TABLE 54 Mexico Corneal Implants Market by End User, 2023 - 2029, USD Million
TABLE 55 Rest of North America Corneal Implants Market, 2019 - 2022, USD Million
TABLE 56 Rest of North America Corneal Implants Market, 2023 - 2029, USD Million
TABLE 57 Rest of North America Corneal Implants Market by Disease Type, 2019 - 2022, USD Million
TABLE 58 Rest of North America Corneal Implants Market by Disease Type, 2023 - 2029, USD Million
TABLE 59 Rest of North America Corneal Implants Market by Procedure Type, 2019 - 2022, USD Million
TABLE 60 Rest of North America Corneal Implants Market by Procedure Type, 2023 - 2029, USD Million
TABLE 61 Rest of North America Corneal Implants Market by End User, 2019 - 2022, USD Million
TABLE 62 Rest of North America Corneal Implants Market by End User, 2023 - 2029, USD Million
TABLE 63 key information – Alcon, Inc.
TABLE 64 Key Information – CorneaGen
TABLE 65 Key Information – CorNeat Vision Ltd.
TABLE 66 Key Information – EyeYon Medical Ltd.
TABLE 67 Key Information – Presbia PLC
TABLE 68 Key Information – AJL Ophthalmic S.A.
TABLE 69 Key Information – LinkoCare Life Sciences AB
TABLE 70 Key Information – KeraMed, Inc.
TABLE 71 Key Information – DIOPTEX GmbH
TABLE 72 Key Information – Mediphacos Indústrias Médicas S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: CorneaGen